Matthias Aizenberg

The aftermath of a stroke often leaves an indelible mark on the brain, creating a landscape of cellular devastation that the body has little inherent power to mend, but a landmark study has now unraveled the sophisticated internal mechanisms that guide stem cells to not only survive in this hostile

A comprehensive analysis of recent oncological research has illuminated a remarkably promising therapeutic strategy for hepatocellular carcinoma (HCC), a notoriously aggressive and increasingly prevalent form of liver cancer. This investigation centers on the synergistic application of two natural

For the millions of people battling chronic nerve pain, where the lightest touch can feel like a searing burn, hope often feels distant. But a groundbreaking study is challenging the way we think about pain, shifting the focus from masking symptoms to repairing the damage at a cellular level. To

In the quiet intensity of an operating room, a surgeon's judgment is paramount, yet distinguishing the exact border between cancerous and healthy thyroid tissue has long remained a perilous blend of skill, experience, and educated guesswork. This critical moment, where a scalpel’s path is decided

Praxis Precision Medicines, a clinical-stage biopharmaceutical company dedicated to developing therapies for complex central nervous system disorders, has made a significant financial move by announcing the pricing of its underwritten public offering, which is expected to generate gross proceeds of

New research from Princeton University’s Ludwig Institute for Cancer Research has untangled the complex and often harmful relationship between a vitamin A derivative and the body's ability to fight cancer, resolving a long-standing paradox about vitamin A's role in oncology and introducing a

In the fast-evolving world of immunology, the race to develop a highly effective oral treatment for psoriasis has reached a fever pitch. With the recent success of Alumis's Phase 3 trials for envudeucitinib, the landscape is poised for a significant shift. We sat down with biopharma expert Ivan

A company once synonymous with capturing cherished family memories through photographic film is now engineering the very building blocks of life-saving medicines, marking one of the most significant corporate transformations in recent history. The name Fujifilm, long associated with vibrant color

The advent of immunotherapy offered a powerful beacon of hope in the fight against advanced melanoma, yet for many patients and their families, that light has remained frustratingly out of reach. These revolutionary treatments, designed to unleash the body's own immune system against cancer, have

The 44 new drugs that gained approval from the FDA's Center for Drug Evaluation and Research in 2025 represented far more than a simple numerical milestone; they collectively heralded a fundamental paradigm shift in the landscape of therapeutic development. This pivotal year was defined not by the